Evicenter
MarkdownMedical informationP&T meetings
Lorundrostat (MLS-101)

Hypertension, in combination with other antihypertensive drugs

Also known as MT-4129
Launch
Not announced
Last updated
198 sources

Product information and disease descriptionProduct descriptionProduct information

Co-prescribed/Concomitant therapies

9 evidence topics · 9 sources

Launch-HTN: background drug classes and other medications at randomization, No. (%)
MedicationLorundrostat 50 mg and then 100 mg (n = 270)Lorundrostat 50 mg (n = 541)Placebo (n = 272)
Taking 2 antihypertensive medications“106 (39.3)”View highlighted excerpt for this quote“213 (39.4)”View highlighted excerpt for this quote“113 (41.5)”View highlighted excerpt for this quote
Taking ≥3 antihypertensive medications“164 (60.7)”View highlighted excerpt for this quote“328 (60.6)”View highlighted excerpt for this quote“159 (58.5)”View highlighted excerpt for this quote
Thiazide or thiazide-like diuretic“259 (95.9)”View highlighted excerpt for this quote“520 (96.1)”View highlighted excerpt for this quote“259 (95.2)”View highlighted excerpt for this quote
ACE inhibitor or ARB“237 (87.8)”View highlighted excerpt for this quote“467 (86.3)”View highlighted excerpt for this quote“225 (82.7)”View highlighted excerpt for this quote
Calcium channel blocker“140 (51.9)”View highlighted excerpt for this quote“278 (51.4)”View highlighted excerpt for this quote“135 (49.6)”View highlighted excerpt for this quote
Glucagon-like peptide-1 receptor agonists“13 (4.8)”View highlighted excerpt for this quote“30 (5.6)”View highlighted excerpt for this quote“9 (3.3)”View highlighted excerpt for this quote
Sodium-glucose cotransporter 2 inhibitors“14 (5.2)”View highlighted excerpt for this quote“21 (3.9)”View highlighted excerpt for this quote“13 (4.8)”View highlighted excerpt for this quote